Home » Stocks » CODX

Co-Diagnostics, Inc. (CODX)

Stock Price: $11.89 USD 0.08 (0.63%)
Updated Jan 20, 2021 4:00 PM EST - Market closed
After-hours: $11.90 +0.01 (0.08%) Jan 20, 7:55 PM
Market Cap 338.42M
Revenue (ttm) 47.52M
Net Income (ttm) 27.94M
Shares Out 28.08M
EPS (ttm) 1.12
PE Ratio 10.60
Forward PE 6.16
Dividend n/a
Dividend Yield n/a
Trading Day January 20
Last Price $11.89
Previous Close $11.82
Change ($) 0.08
Change (%) 0.63%
Day's Open 11.90
Day's Range 11.41 - 12.11
Day's Volume 1,249,280
52-Week Range 1.88 - 30.80

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
The Motley Fool - 5 days ago

This business came into 2020 as an unknown, and now it's generating so much growth it makes even high-profile IPOs look like they're standing still.

Seeking Alpha - 1 week ago

Co-Diagnostics is well positioned to benefit from incremental fundamental momentum seen at the back end of 2020. The company's Covid-19 tests are differentiated by distinguishing between commo...

The Motley Fool - 1 week ago

These winners are positioned for gains even after COVID.

Other stocks mentioned: FLGT, GNMK, NTRA, AWH
PRNewsWire - 1 week ago

SALT LAKE CITY, Jan. 7, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of mol...

PRNewsWire - 2 weeks ago

SALT LAKE CITY, Jan. 6, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of mol...

The Motley Fool - 2 weeks ago

These companies are developing highly competitive vaccines and diagnostics.

Other stocks mentioned: ABT, JNJ
The Motley Fool - 2 weeks ago

Not all of them were COVID-19 vaccine makers.

Other stocks mentioned: NVAX, VXRT
The Motley Fool - 2 weeks ago

Investors in fast-moving biotechs made out like bandits.

Other stocks mentioned: FLGT, INO, MRNA, ARCT
Seeking Alpha - 4 weeks ago

Three referenced quant rating categories (value, growth, and profitability) are significant considerations in selecting healthcare investments. The data underlying the value, growth, and profi...

Other stocks mentioned: CPRX, QDEL
The Motley Fool - 4 weeks ago

These stocks have made investors richer by posting explosive revenue growth or advancing significantly in high-impact programs.

Other stocks mentioned: CLDX, CRDF, RVP, VXRT
PRNewsWire - 4 weeks ago

SALT LAKE CITY, Dec. 22, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molec...

The Motley Fool - 1 month ago

The highest performers of the year are biotechs fighting COVID-19 and cancer. Are they still buys for 2021?

Other stocks mentioned: BNTX, CLDX, CRDF, MCRB, MRNA, NSRGY, NVAX, TRIL, VXRT
PRNewsWire - 1 month ago

SALT LAKE CITY, Dec. 14, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molec...

The Motley Fool - 1 month ago

The company has unbelievable top-line growth right now, and has profit margins over 60%. Will the stock continue to ride high once the world is vaccinated?

The Motley Fool - 1 month ago

The company's joint venture in India received good news.

PRNewsWire - 1 month ago

SALT LAKE CITY, Nov. 25, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molec...

The Motley Fool - 2 months ago

The company badly missed Wall Street earnings estimate for the third quarter.

PRNewsWire - 2 months ago

SALT LAKE CITY, Nov. 17, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic ...

Seeking Alpha - 2 months ago

Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q3 2020 Results - Earnings Call Transcript

PRNewsWire - 2 months ago

SALT LAKE CITY, Nov. 16, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic ...

OTC PR Wire - 2 months ago

The Virus Testing Stocks Pullback Opportunity (NASDAQ: CODX) (NASDAQ: FLGT) (OTC: ALST) (NYSE: LH)

Other stocks mentioned: FLGT, LH, ALST
PRNewsWire - 2 months ago

SALT LAKE CITY, Nov. 11, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic ...

PRNewsWire - 2 months ago

SALT LAKE CITY, Nov. 10, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic ...

Zacks Investment Research - 2 months ago

Co-Diagnostics' (CODX) third-quarter results are likely to reflect higher COVID-19 test sales.

PRNewsWire - 2 months ago

SALT LAKE CITY, Utah, Nov. 2, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagno...

Investopedia - 2 months ago

These are the small cap stocks with the best value, fastest growth, and most momentum for November 2020.

Other stocks mentioned: BIG, NVAX, TGH, TTMI, UIS, VHC, VXRT, XBIT
The Motley Fool - 2 months ago

Co-Diagnostics has had a wild run this year. Is it too late to get in on this booming biotech stock?

Zacks Investment Research - 3 months ago

CoDiagnostics, Inc. (CODX) closed the most recent trading day at $14.42, moving +0.07% from the previous trading session.

The Motley Fool - 3 months ago

Shares of the COVID-19 test maker remain very volatile.

Zacks Investment Research - 3 months ago

Investors need to pay close attention to Co-Diagnostics (CODX) stock based on the movements in the options market lately.

PRNewsWire - 3 months ago

SALT LAKE CITY, Oct. 2, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, anno...

Investopedia - 3 months ago

These are the small cap stocks with the best value, fastest growth, and most momentum for October 2020.

Other stocks mentioned: BIG, NVAX, TGH, TTMI, UIS, VHC, VXRT, XBIT
GuruFocus - 3 months ago

Massive amounts allocated to the purchase of fixed assets may anticipate higher stock prices

Other stocks mentioned: LIND, PAGS
PRNewsWire - 3 months ago

SALT LAKE CITY, Sept. 24, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, an...

The Motley Fool - 4 months ago

The company's stock had a huge week after announcing that Arches Research has signed a deal to use its coronavirus test kit.

PRNewsWire - 4 months ago

SALT LAKE CITY, Sept. 11, 2020 /PRNewswire/ -- Co-Diagnostics, Inc.

The Motley Fool - 4 months ago

Even top diagnostic test producers got hit hard in late August.

Other stocks mentioned: BDX, FLDM
24/7 Wall Street - 4 months ago

Co-Diagnostics, Inc. (NASDAQ: CODX) shares shot up on Tuesday after the company announced that it has entered into an agreement with Arches Research to expand Arches’ COVID-19 testing services...

The Motley Fool - 4 months ago

Good news could be fueling a short squeeze.

Business Wire - 4 months ago

SALT LAKE CITY--(BUSINESS WIRE)--PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, today announced that its subsidiary, Arches R...

The Motley Fool - 4 months ago

The most likely culprit: continued concerns about a competitor's new product.

PRNewsWire - 4 months ago

SALT LAKE CITY, Sept. 1, 2020 /PRNewswire/ -- Co-Diagnostics, Inc.

Investopedia - 4 months ago

These are the small cap stocks with the best value, fastest growth, and most momentum for September.

Other stocks mentioned: ICHR, NVAX, PRTS, TGH, TTM, UIS, VHC, XBIT
Benzinga - 4 months ago

Abbott Laboratories (NYSE: ABT) announced late Wednesday the receipt of emergency use authorization from the FDA for its $5, 15-minute COVID-19 antigen test.

Other stocks mentioned: GNMK, QDEL
The Motley Fool - 4 months ago

Blame it on Abbott.

Other stocks mentioned: GNMK, LMNX, OPK
The Motley Fool - 4 months ago

It's not a surprise that all five of these stocks are engaged in the fight against the novel coronavirus.

Other stocks mentioned: ALT, IBIO, NVAX, VXRT
PRNewsWire - 4 months ago

SALT LAKE CITY, Aug. 25, 2020 /PRNewswire/ -- Co-Diagnostics, Inc.

PRNewsWire - 5 months ago

SALT LAKE CITY, Aug. 20, 2020 /PRNewswire/ -- Co-Diagnostics, Inc.

Seeking Alpha - 5 months ago

Co-Diagnostics Inc. (CODX) CEO Dwight H Egan on Q2 2020 Results - Earnings Call Transcript

Newsfile Corp - 5 months ago

Los Angeles, California--(Newsfile Corp. - August 17, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Co-Diag...

About CODX

Co-Diagnostics, a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.

Industry
Diagnostics & Research
IPO Date
Jul 12, 2017
CEO
Dwight Egan
Employees
39
Stock Exchange
NASDAQ
Ticker Symbol
CODX
Full Company Profile

Financial Performance

In 2019, Co-Diagnostics's revenue was $214,974, an increase of 438.63% compared to the previous year's $39,911. Losses were -$6.20 million, -1.21% less than in 2018.

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for Co-Diagnostics stock is "Buy." The 12-month stock price forecast is 31.00, which is an increase of 160.72% from the latest price.

Price Target
$31.00
(160.72% upside)
Analyst Consensus: Buy